Works by Erlichman, Charles

Results: 49

Epidermal growth factor receptor and activated epidermal growth factor receptor expression in gastrointestinal carcinoids and pancreatic endocrine carcinomas.

Published in:

Modern Pathology, 2005, v. 18, n. 10, p. 1329, doi. 10.1038/modpathol.3800427

By:

Papouchado, Bettina;
Erickson, Lori A.;
Rohlinger, Audrey L.;
Hobday, Timothy J.;
Erlichman, Charles;
Ames, Matthew M.;
Lloyd, Ricardo V.

Publication type:

Article

A limited sample model to predict area under the drug concentration curve for 17-(allylamino)-17-demethoxygeldanamycin and its active metabolite 17-(amino)-17-demethoxygeldanomycin.

Published in:

Cancer Chemotherapy & Pharmacology, 2008, v. 61, n. 1, p. 39, doi. 10.1007/s00280-007-0443-6

By:

Furth, Alfred F.;
Mandrekar, Sumithra J.;
Tan, Angelina D.;
Rau, Andrea;
Felten, Sara J.;
Ames, Matthew M.;
Adjei, Alex A.;
Erlichman, Charles;
Reid, Joel M.

Publication type:

Article

A phase I and pharmacologic study of sequences of the proteasome inhibitor, bortezomib (PS-341, Velcade™), in combination with paclitaxel and carboplatin in patients with advanced malignancies.

Published in:

Cancer Chemotherapy & Pharmacology, 2007, v. 59, n. 2, p. 207, doi. 10.1007/s00280-006-0259-9

By:

Ma, Cynthia;
Mandrekar, Sumithra J.;
Alberts, Steven R.;
Croghan, Gary A.;
Jatoi, Aminah;
Reid, Joel M.;
Hanson, Lorelei J.;
Bruzek, Laura;
Tan, Angelina D.;
Pitot, Henry C.;
Erlichman, Charles;
Wright, John J.;
Adjei, Alex A.

Publication type:

Article

A phase I and pharmacokinetic study of a powder-filled capsule formulation of oral irinotecan (CPT-11) given daily for 5 days every 3 weeks in patients with advanced solid tumors.

Published in:

2006

By:

Pitot, Henry C.;
Adjei, Alex A.;
Reid, Joel M.;
Sloan, Jeff A.;
Atherton, Pamela J.;
Rubin, Joseph;
Alberts, Steven R.;
Duncan, Barbara A.;
Denis, Louis;
Schaaf, Larry J.;
Donghua Yin;
Sharma, Amarnath;
McGovren, Patrick;
Miller, Langdon L.;
Erlichman, Charles;
Yin, Donghua

Publication type:

journal article

A phase IB study of the pharmacokinetics of gemcitabine and pemetrexed, when administered in rapid sequence to patients with advanced solid tumors.

Published in:

Cancer Chemotherapy & Pharmacology, 2005, v. 55, n. 6, p. 522, doi. 10.1007/s00280-004-0950-7

By:

Dy, Grace K.;
Suri, Ajit;
Reid, Joel M.;
Sloan, Jeff A.;
Pitot, Henry C.;
Alberts, Steven R.;
Goldberg, Richard M.;
Atherton, Pamela J.;
Hanson, Lorelei J.;
Burch, Patrick A.;
Rubin, Joseph;
Erlichman, Charles;
Adjei, Alex

Publication type:

Article

Limited sampling models for CPT-11, SN-38, and SN-38 glucuronide.

Published in:

2001

By:

Sloan, Jeff A.;
Atherton, Pamela;
Reid, Joel;
Pitot, Henry C.;
Erlichman, Charles;
Schaaf, Larry;
Sloan, J A;
Atherton, P;
Reid, J;
Pitot, H C;
Erlichman, C;
Schaaf, L

Publication type:

journal article

An Evaluation of Postoperative Follow-Up Tests in Colon Cancer Patients Treated for Cure.

Published in:

Oncology, 1997, v. 54, n. 4, p. 287, doi. 10.1159/000227705

By:

Peethambaram, Prema;
Weiss, Matthias;
Loprinzi, Charles L.;
Novotny, Paul;
O'Fallon, Judith R.;
Erlichman, Charles;
O'Connell, Michael J.;
Laurie, John A.

Publication type:

Article

Levamisole and 5-fluorouracil therapy for resected colon cancer: a new indication.

Published in:

Canadian Medical Association Journal (CMAJ), 1991, v. 144, n. 3, p. 297

By:

Skillings, Jamey R.;
Levine, Mark;
Rayner, H. L.;
Eisenhauer, Elizabeth;
Erlichman, Charles;
Germond, Colin;
Kerr, Ian;
Lofters, Wycliffe;
Maroun, Jean;
Yoshida, Sam

Publication type:

Article

UGT1A1 genotype-guided phase I study of irinotecan, oxaliplatin, and capecitabine.

Published in:

Investigational New Drugs, 2013, v. 31, n. 6, p. 1559, doi. 10.1007/s10637-013-0034-9

By:

Goetz, Matthew;
McKean, Heidi;
Reid, Joel;
Mandrekar, Sumithra;
Tan, Angelina;
Kuffel, Mary;
Safgren, Stephanie;
McGovern, Renee;
Goldberg, Richard;
Grothey, Axel;
McWilliams, Robert;
Erlichman, Charles;
Ames, Matthew

Publication type:

Article

Phase I study of tanespimycin in combination with bortezomib in patients with advanced solid malignancies.

Published in:

Investigational New Drugs, 2013, v. 31, n. 5, p. 1251, doi. 10.1007/s10637-013-9946-7

By:

Schenk, Erin;
Hendrickson, Andrea;
Northfelt, Donald;
Toft, David;
Ames, Matthew;
Menefee, Michael;
Satele, Daniel;
Qin, Rui;
Erlichman, Charles

Publication type:

Article

Phase 1 study of sorafenib in combination with bortezomib in patients with advanced malignancies.

Published in:

Investigational New Drugs, 2013, v. 31, n. 5, p. 1201, doi. 10.1007/s10637-013-0004-2

By:

Kumar, Shaji;
Jett, James;
Marks, Randolph;
Richardson, Ronald;
Quevedo, Fernando;
Moynihan, Timothy;
Croghan, Gary;
Markovic, Svetomir;
Bible, Keith;
Qin, Rui;
Tan, Angelina;
Molina, Julian;
Kaufmann, Scott;
Erlichman, Charles;
Adjei, Alex

Publication type:

Article

Phase I study of temsirolimus in combination with EKB-569 in patients with advanced solid tumors.

Published in:

Investigational New Drugs, 2012, v. 30, n. 5, p. 1934, doi. 10.1007/s10637-011-9742-1

By:

Bryce, Alan;
Rao, Ravi;
Sarkaria, Jann;
Reid, Joel;
Qi, Yingwei;
Qin, Rui;
James, C.;
Jenkins, Robert;
Boni, Joseph;
Erlichman, Charles;
Haluska, Paul

Publication type:

Article

An international, multicenter phase II trial of bortezomib in patients with hepatocellular carcinoma.

Published in:

Investigational New Drugs, 2012, v. 30, n. 1, p. 387, doi. 10.1007/s10637-010-9532-1

By:

Kim, George;
Mahoney, Michelle;
Szydlo, Daniel;
Mok, Tony;
Marshke, Robert;
Holen, Kyle;
Picus, Joel;
Boyer, Michael;
Pitot, Henry;
Rubin, Joseph;
Philip, Philip;
Nowak, Anna;
Wright, John;
Erlichman, Charles

Publication type:

Article

Phase I study of 17-allylamino-17 demethoxygeldanamycin, gemcitabine and/or cisplatin in patients with refractory solid tumors.

Published in:

Investigational New Drugs, 2011, v. 29, n. 3, p. 473, doi. 10.1007/s10637-009-9381-y

By:

Hubbard, Joleen;
Erlichman, Charles;
Toft, David;
Qin, Rui;
Stensgard, Bridget;
Felten, Sara;
Ten Eyck, Cynthia;
Batzel, Gretchen;
Ivy, S.;
Haluska, Paul

Publication type:

Article

Phase I, pharmacokinetic study of temsirolimus administered orally to patients with advanced cancer.

Published in:

Investigational New Drugs, 2010, v. 28, n. 3, p. 334, doi. 10.1007/s10637-009-9257-1

By:

Buckner, Jan;
Forouzesh, Bahram;
Erlichman, Charles;
Hidalgo, Manuel;
Boni, Joseph;
Dukart, Gary;
Berkenblit, Anna;
Rowinsky, Eric

Publication type:

Article

A phase 2 consortium (P2C) trial of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP) for advanced adenocarcinoma of the pancreas.

Published in:

Investigational New Drugs, 2008, v. 26, n. 4, p. 369, doi. 10.1007/s10637-008-9123-6

By:

Steven Attia;
Jill Kolesar;
Michelle Mahoney;
Henry Pitot;
Daniel Laheru;
James Heun;
Wei Huang;
Jens Eickhoff;
Charles Erlichman;
Kyle Holen

Publication type:

Article

A phase I clinical and pharmacokinetic study of CS-682 administered orally in advanced malignant solid tumors.

Published in:

Investigational New Drugs, 2006, v. 24, n. 4, p. 327, doi. 10.1007/s10637-006-5392-0

By:

Thierry Delaunoit;
Patrick Burch;
Joel Reid;
John Camoriano;
Tomowo Kobayash;
Theodore Braich;
Judith Kaur;
Joseph Rubin;
Charles Erlichman

Publication type:

Article

Development of Rational Drug Combinations with Investigational Targeted Agents.

Published in:

Oncologist, 2010, v. 15, n. 5, p. 496, doi. 10.1634/theoncologist.2009-0262

By:

Clark, Adam;
Ellis, Matthew;
Erlichman, Charles;
Lutzker, Stuart;
Zwiebel, James

Publication type:

Article

A phase II study of AZD2171 (cediranib) in the treatment of patients with acute myeloid leukemia or high-risk myelodysplastic syndrome.

Published in:

Leukemia & Lymphoma, 2015, v. 56, n. 7, p. 2061, doi. 10.3109/10428194.2014.977886

By:

Mattison, Ryan;
Jumonville, Alcee;
Flynn, Patrick James;
Moreno-Aspitia, Alvaro;
Erlichman, Charles;
LaPlant, Betsy;
Juckett, Mark B.

Publication type:

Article

Akt inhibitor MK-2206 in combination with bendamustine and rituximab in relapsed or refractory chronic lymphocytic leukemia: Results from the N1087 alliance study.

Published in:

American Journal of Hematology, 2017, v. 92, n. 8, p. 759, doi. 10.1002/ajh.24762

By:

Larsen, Jeremy T.;
Shanafelt, Tait D.;
Leis, Jose F.;
LaPlant, Betsy;
Call, Tim;
Pettinger, Adam;
Hanson, Curtis;
Erlichman, Charles;
Habermann, Thomas Matthew;
Reeder, Craig;
Nikcevich, Daniel;
Bowen, Deborah;
Conte, Michael;
Boysen, Justin;
Secreto, Charla;
Lesnick, Connie;
Tschumper, Renee;
Jelinek, Diane;
Kay, Neil E.;
Ding, Wei

Publication type:

Article

Molecular markers in male breast carcinoma.

Published in:

1998

By:

Rayson, Daniel;
Erlichman, Charles;
Suman, Vera J.;
Roche, Patrick C.;
Wold, Lester E.;
Ingle, James N.;
Donohue, John H.;
Rayson, D;
Erlichman, C;
Suman, V J;
Roche, P C;
Wold, L E;
Ingle, J N;
Donohue, J H

Publication type:

journal article

Phase II study of the histone deacetylase inhibitor belinostat (PXD101) for the treatment of myelodysplastic syndrome (MDS).

Published in:

Annals of Hematology, 2012, v. 91, n. 1, p. 33, doi. 10.1007/s00277-011-1240-1

By:

Cashen, Amanda;
Juckett, Mark;
Jumonville, Alcee;
Litzow, Mark;
Flynn, P.;
Eckardt, John;
LaPlant, Betsy;
Laumann, Kristina;
Erlichman, Charles;
DiPersio, John

Publication type:

Article

Phase 2 trial of daily, oral polyphenon E in patients with asymptomatic, Rai stage 0 to II chronic lymphocytic leukemia.

Published in:

Cancer (0008543X), 2013, v. 119, n. 2, p. 363, doi. 10.1002/cncr.27719

By:

Shanafelt, Tait D.;
Call, Timothy G.;
Zent, Clive S.;
Leis, Jose F.;
LaPlant, Betsy;
Bowen, Deborah A.;
Roos, Michelle;
Laumann, Kristina;
Ghosh, Asish K.;
Lesnick, Connie;
Lee, Mao-Jung;
Yang, Chung S.;
Jelinek, Diane F.;
Erlichman, Charles;
Kay, Neil E.

Publication type:

Article

Phase 2 study of bevacizumab plus erlotinib in patients with advanced hepatocellular cancer.

Published in:

Cancer (0008543X), 2012, v. 118, n. 9, p. 2424, doi. 10.1002/cncr.26556

By:

Philip, Philip A.;
Mahoney, Michelle R.;
Holen, Kyle D.;
Northfelt, Donald W.;
Pitot, Henry C.;
Picus, Joel;
Flynn, Patrick J.;
Erlichman, Charles

Publication type:

Article

A phase I study of cilengitide and paclitaxel in patients with advanced solid tumors.

Published in:

2017

By:

Haddad, Tufia;
Qin, Rui;
Lupu, Ruth;
Satele, Daniel;
Eadens, Matthew;
Goetz, Matthew;
Erlichman, Charles;
Molina, Julian;
Goetz, Matthew P

Publication type:

journal article

Safety and activity of temsirolimus and bevacizumab in patients with advanced renal cell carcinoma previously treated with tyrosine kinase inhibitors: a phase 2 consortium study.

Published in:

Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 3, p. 485, doi. 10.1007/s00280-014-2668-5

By:

Merchan, Jaime;
Qin, Rui;
Pitot, Henry;
Picus, Joel;
Liu, Glenn;
Fitch, Tom;
Maples, William;
Flynn, Patrick;
Fruth, Briant;
Erlichman, Charles

Publication type:

Article

A hierarchical Bayesian design for randomized Phase II clinical trials with multiple groups.

Published in:

Journal of Biopharmaceutical Statistics, 2018, v. 28, n. 3, p. 451, doi. 10.1080/10543406.2017.1321007

By:

Yin, Jun;
Qin, Rui;
Sargent, Daniel J.;
Erlichman, Charles;
Shi, Qian

Publication type:

Article

Akt inhibitor MK2206 selectively targets CLL B-cell receptor induced cytokines, mobilizes lymphocytes and synergizes with bendamustine to induce CLL apoptosis.

Published in:

British Journal of Haematology, 2014, v. 164, n. 1, p. 146, doi. 10.1111/bjh.12564

By:

Ding, Wei;
Shanafelt, Tait D.;
Lesnick, Connie E.;
Erlichman, Charles;
Leis, Jose F.;
Secreto, Charla;
Sassoon, Traci R.;
Call, Timothy G.;
Bowen, Deborah A.;
Conte, Michael;
Kumar, Shaji;
Kay, Neil E.

Publication type:

Article

Gemcitabine and Irinotecan as First-Line Therapy for Carcinoma of Unknown Primary: Results of a Multicenter Phase II Trial.

Published in:

PLoS ONE, 2012, v. 7, n. 7, p. 1, doi. 10.1371/journal.pone.0039285

By:

Holtan, Shernan G.;
Steen, Preston D.;
Foster, Nathan R.;
Erlichman, Charles;
Medeiros, Fabiola;
Ames, Matthew M.;
Safgren, Stephanie L.;
Graham, David L.;
Behrens, Robert J.;
Goetz, Matthew P.

Publication type:

Article

A phase 2 study of temsirolimus (CCI-779) in patients with soft tissue sarcomas: a study of the Mayo phase 2 consortium (P2C).

Published in:

2011

By:

Okuno S;
Bailey H;
Mahoney MR;
Adkins D;
Maples W;
Fitch T;
Ettinger D;
Erlichman C;
Sarkaria JN;
Okuno, Scott;
Bailey, Howard;
Mahoney, Michelle R;
Adkins, Douglas;
Maples, William;
Fitch, Tom;
Ettinger, David;
Erlichman, Charles;
Sarkaria, Jann N

Publication type:

journal article

A phase 2 study of temsirolimus (CCI-779) in patients with soft tissue sarcomas.

Published in:

Cancer (0008543X), 2011, v. 117, n. 15, p. 3468, doi. 10.1002/cncr.25928

By:

Okuno, Scott;
Bailey, Howard;
Mahoney, Michelle R.;
Adkins, Douglas;
Maples, William;
Fitch, Tom;
Ettinger, David;
Erlichman, Charles;
Sarkaria, Jann N.

Publication type:

Article

A study of paclitaxel, carboplatin, and bortezomib in the treatment of metastatic malignant melanoma: a phase 2 consortium study.

Published in:

2010

By:

Croghan GA;
Suman VJ;
Maples WJ;
Albertini M;
Linette G;
Flaherty L;
Eckardt J;
Ma C;
Markovic SN;
Erlichman C;
Croghan, Gary A;
Suman, Vera J;
Maples, William J;
Albertini, Mark;
Linette, Gerald;
Flaherty, Lawrence;
Eckardt, John;
Ma, Cynthia;
Markovic, Svetomir N;
Erlichman, Charles

Publication type:

journal article

A Study of Paclitaxel, Carboplatin, and Bortezomib in the Treatment of Metastatic Malignant Melanoma.

Published in:

Cancer (0008543X), 2010, v. 116, n. 14, p. 3463, doi. 10.1002/cncr.25191

By:

Croghan, Gary A.;
Suman, Vera J.;
Maples, William J.;
Albertini, Mark;
Linette, Gerald;
Flaherty, Lawrence;
Eckardt, John;
Ma, Cynthia;
Markovic, Svetomir N.;
Erlichman, Charles

Publication type:

Article

Phase II study of daily oral perifosine in patients with advanced soft tissue sarcoma.

Published in:

Cancer (0008543X), 2006, v. 107, n. 10, p. 2462, doi. 10.1002/cncr.22308

By:

Bailey, Howard H.;
Mahoney, Michelle R.;
Ettinger, David S.;
Maples, William J.;
Fracasso, Paula M.;
Traynor, Anne M.;
Erlichman, Charles;
Okuno, Scott H.

Publication type:

Article

A phase II study of bortezomib in the treatment of metastatic malignant melanoma.

Published in:

Cancer (0008543X), 2005, v. 103, n. 12, p. 2584

By:

Svetomir N. Markovic;
Susan M. Geyer;
Fitzroy Dawkins;
William Sharfman;
Mark Albertini;
William Maples;
Paula M. Fracasso;
Tom Fitch;
Patricia LoRusso;
Alex A. Adjei;
Charles Erlichman

Publication type:

Article

Irinotecan in the treatment of glioma patients: current and future studies of the North Central Cancer Treatment Group.

Published in:

2003

By:

Buckner, Jan C;
Reid, Joel M;
Wright, Keith;
Kaufmann, Scott H;
Erlichman, Charles;
Ames, Matthew;
Cha, Steve;
O'Fallon, Judith R;
Schaaf, Lawrence J;
Miller, Langdon L

Publication type:

journal article

Irinotecan in the treatment of glioma patients (These studies are being conducted as a collaborative effort of the North Central Cancer Treatment Group, Mayo Clinic, and Pharmacia Corporation.).

Published in:

Cancer (0008543X), 2003, v. 97, p. 2352

By:

Jan C. Buckner;
Joel M. Reid;
Keith Wright;
Scott H. Kaufmann;
Charles Erlichman;
Matthew Ames;
Steve Cha;
Judith R. O'Fallon;
Lawrence J. Schaaf;
Langdon L. Miller

Publication type:

Article

A phase 2 study of MK‐2206 in patients with incurable adenoid cystic carcinoma (Alliance A091104).

Published in:

Cancer (0008543X), 2024, v. 130, n. 5, p. 702, doi. 10.1002/cncr.35103

By:

Ho, Alan L.;
Foster, Nathan R.;
Deraje Vasudeva, Shyamprasad;
Katabi, Nora;
Antonescu, Cristina R.;
Frenette, Gary P.;
Pfister, David G.;
Erlichman, Charles;
Schwartz, Gary K.

Publication type:

Article

Medical Management of Pancreatic Neuroendocrine Tumors.

Published in:

American Journal of Gastroenterology (Springer Nature), 2008, v. 103, n. 2, p. 475, doi. 10.1111/j.1572-0241.2007.01643.x

By:

Delaunoit, Thierry;
Neczyporenko, Florence;
Rubin, Joseph;
Erlichman, Charles;
Hobday, Timothy J.

Publication type:

Article

Pathogenesis and Risk Factors of Small Bowel Adenocarcinoma: A Colorectal Cancer Sibling?

Published in:

American Journal of Gastroenterology (Springer Nature), 2005, v. 100, n. 3, p. 703, doi. 10.1111/j.1572-0241.2005.40605.x

By:

Delaunoit, Thierry;
Neczyporenko, Florence;
Limburg, Paul J.;
Erlichman, Charles

Publication type:

Article

Phase I study of cediranib, an oral VEGFR inhibitor, in combination with selumetinib, an oral MEK inhibitor, in patients with advanced solid malignancies.

Published in:

Investigational New Drugs, 2022, v. 40, n. 1, p. 115, doi. 10.1007/s10637-021-01175-6

By:

Hubbard, Joleen M.;
Yin, Jun;
Schenk, Erin L.;
Qin, Rui;
Reid, Joel M.;
Strand, Carrie;
Fiskum, Jack;
Menefee, Michael;
Lin, Grace;
Doyle, L. Austin;
Ivy, Percy;
Erlichman, Charles;
Adjei, Alex;
Haluska, Paul;
Costello, Brian A.

Publication type:

Article

A phase II study of the orally administered negative enantiomer of gossypol (AT-101), a BH3 mimetic, in patients with advanced adrenal cortical carcinoma.

Published in:

Investigational New Drugs, 2019, v. 37, n. 4, p. 755, doi. 10.1007/s10637-019-00797-1

By:

Xie, Hao;
Yin, Jun;
Shah, Manisha H.;
Menefee, Michael E.;
Bible, Keith C.;
Reidy-Lagunes, Diane;
Kane, Madeleine A.;
Quinn, David I.;
Gandara, David R.;
Erlichman, Charles;
Adjei, Alex A.

Publication type:

Article

Phase I trial of FOLFIRI in combination with sorafenib and bevacizumab in patients with advanced gastrointestinal malignancies.

Published in:

Investigational New Drugs, 2016, v. 34, n. 1, p. 96, doi. 10.1007/s10637-015-0308-5

By:

Hubbard, Joleen;
Kim, George;
Borad, Mitesh;
Johnson, Elizabeth;
Qin, Rui;
Lensing, Janet;
Puttabasavaiah, Suneetha;
Wright, John;
Erlichman, Charles;
Grothey, Axel

Publication type:

Article

Phase II trial of gemcitabine and tanespimycin (17AAG) in metastatic pancreatic cancer: a Mayo Clinic Phase II Consortium study.

Published in:

Investigational New Drugs, 2015, v. 33, n. 4, p. 963, doi. 10.1007/s10637-015-0246-2

By:

Pedersen, Katrina;
Kim, George;
Foster, Nathan;
Wang-Gillam, Andrea;
Erlichman, Charles;
McWilliams, Robert

Publication type:

Article

A phase II trial of bevacizumab plus temsirolimus in patients with advanced hepatocellular carcinoma.

Published in:

Investigational New Drugs, 2015, v. 33, n. 1, p. 241, doi. 10.1007/s10637-014-0169-3

By:

Knox, Jennifer;
Qin, Rui;
Strosberg, Jonathan;
Tan, Benjamin;
Kaubisch, Andreas;
El-Khoueiry, Anthony;
Bekaii-Saab, Tanios;
Rousey, Steven;
Chen, Helen;
Erlichman, Charles

Publication type:

Article

Phase I trial of everolimus, gemcitabine and cisplatin in patients with solid tumors.

Published in:

Investigational New Drugs, 2014, v. 32, n. 4, p. 710, doi. 10.1007/s10637-014-0096-3

By:

Costello, Brian;
Borad, Mitesh;
Qi, Yingwei;
Kim, George;
Northfelt, Donald;
Erlichman, Charles;
Alberts, Steven

Publication type:

Article

A phase I trial of the IGF-1R antibody Cixutumumab in combination with temsirolimus in patients with metastatic breast cancer.

Published in:

Breast Cancer Research & Treatment, 2013, v. 139, n. 1, p. 145, doi. 10.1007/s10549-013-2528-8

By:

Ma, Cynthia;
Suman, Vera;
Goetz, Matthew;
Haluska, Paul;
Moynihan, Timothy;
Nanda, Rita;
Olopade, Olufunmilayo;
Pluard, Timothy;
Guo, Zhanfang;
Chen, Helen;
Erlichman, Charles;
Ellis, Matthew;
Fleming, Gini

Publication type:

Article

Superiority of Granisetron to Dexamethasone Plus Prochlorperazine in the Prevention of Chemotherapy-Induced Emesis.

Published in:

JNCI: Journal of the National Cancer Institute, 1991, v. 83, n. 16, p. 1169, doi. 10.1093/jnci/83.16.1169

By:

Warr, David;
Willan, Andrew;
Fine, Sheldon;
Wilson, Kenneth;
Davis, Alan;
Erlichman, Charles;
Rusthoven, James;
Lofters, Wycliffe;
Osoba, David;
Laberge, Francis;
Latreille, Jean;
Pater, Joseph

Publication type:

Article

Phase II trials of single-agent anti-VEGF therapy for patients with chronic lymphocytic leukemia.

Published in:

Leukemia & Lymphoma, 2010, v. 51, n. 12, p. 2222, doi. 10.3109/10428194.2010.524327

By:

Shanafelt, Tait;
Zent, Clive;
Byrd, John;
Erlichman, Charles;
Laplant, Betsy;
Ghosh, Asish;
Call, Timothy;
Villalona-Calero, Miguel;
Jelinek, Diane;
Bowen, Deborah;
Laumann, Kristina;
Wu, Wenting;
Hanson, Curtis;
Kay, Neil

Publication type:

Article